On the evening of 14 June 2022, the Guangdong-Hong Kong-Macao-Bay Area (GBA) Economic And Trade Association held the 2022 GBA Awards Presentation Ceremony at the JW Marriott Hotel Hong Kong. Fosun International was awarded the “GBA ESG Inheritage Award 2022” in recognition of its active promotion of the GBA and global economic development, as well as its contributions and achievements in environmental, social and corporate governance (ESG).

The Award Commends Fosun for Actively Promoting the Sustainable Development of “China + the World”

The judging committee of the GBA Economic And Trade Association pointed out that Fosun has been actively promoting the sustainable development of “China + the World” with its globalization capabilities of “global organization + local operations”. When conducting business globally, in addition to emphasizing respect for local culture, it has always attached great importance to responsible investment, integrating the concept of sustainable development into its investment and management and operation of business in various regions.

In August 2014, Fosun joined the United Nations Global Compact (UNGC) and is devoted to the global commitment to sustainable development, promoting the achievement of the United Nations (UN) Sustainable Development Goals (SDGs) through participating in related activities globally and locally. As a participant in the UNGC, Fosun supports the ten principles of UNGC in the areas of human rights, labor, environment and anti-corruption, relentlessly promoting their close integration with Fosun’s ESG strategies and actively engaging its member companies in the implementation of ESG strategies.

The association also pointed out thatwith the global trend of promoting carbon neutrality, carbon emissions reduction, and sustainable development of the Earth, Fosun has established a Carbon Neutrality Committee to actively promote the implementation of the “Dual Carbon” strategy of each member company, and set “Dual Carbon” goals for the Group – “Striving to achieve carbon emissions peak by 2028 and carbon neutrality by 2050”. Fosun continuously promotes the implementation of carbon neutrality management across the Group, and actively promotes the transition to a low-carbon economy.

Fosun’s Anti-pandemic and Anti-malaria Efforts Demonstrate its Corporate Social Responsibility

The judging committee of the GBA Economic And Trade Association pointed out the COVID-19 pandemic that has swept the world since the beginning of 2020 has posed huge challenges for companies around the world. However, Fosun has shown strong resilience and adaptability in mitigating the impact of the pandemic on its business during the pandemic; while actively responding to the pandemic, the Group fully supports the fight against the pandemic, tides over the difficulties with the whole society, demonstrating strong social responsibility and mission.

When the fifth wave of the epidemic broke out in Hong Kong at the beginning of this year, Fosun immediately donated anti-epidemic materials worth HK$10 million. The photo shows that Fosun presenting COVID-19 rapid antigen test kits to the Boys' and Girls' Clubs Association of Hong Kong.

The judging committee specifically pointed out that when the fifth wave of the epidemic broke out in Hong Kong at the beginning of this year, Fosun immediately donated anti-epidemic materials worth HK$10 million to those in need in Hong Kong, including high-risk groups such as the elderly, chronically ill patients, children, and front-line anti-epidemic personnel, and grassroots families. In the fight against the pandemic, at the beginning of the outbreak, Fosun partnered with BioNTech, a German biotechnology company, to jointly develop the COVID-19 mRNA vaccine, playing an active role in the pandemic prevention and control.

 

Fosun Pharma continues to supply COMIRNATY^® (COVID-10 mRNA vaccine) to Hong Kong SAR, Macau SAR, and Taiwan region, building an immune barrier for the regions.

As of the end of March 2022, Fosun Pharma has supplied a cumulative of more than 24 million doses of COMIRNATY^® (mRNA COVID-10 vaccine) to Hong Kong SAR, Macau SAR and Taiwan region. In addition, in the first quarter of 2022, Fosun Pharma obtained licensed from the Medicines Patent Pool (MPP) to produce and supply the generic version of Merck's oral COVID-19 treatment Molnupiravir and Pfizer's oral COVID-19 treatment Nirmatrelvir in combination with Ritonavir to agreed low- and middle-income countries. The license includes the rights to manufacture both ingredients and the finished drug. Fosun Pharma strives to improve the accessibility and affordability of COVID-19 treatments in low- and middle-income countries or regions around the world. Fosun has been actively cooperating with its subsidiaries and continued to contribute to the global fight against the pandemic.

Fosun assists Africa in fighting against malaria. Together We Build a Malaria-Free World.

Regarding global health promotion, Fosun has participated in the joint construction of a “malaria-free world” for more than 15 years. As the first Chinese pharmaceutical brand well recognized in Africa, Artesun^® (artesunate for injection), self-developed and manufactured by Fosun Pharma, has been used to treat over 48 million severe malaria patients worldwide by the end of 2021. Fosun Pharma continues to innovate, its SPAQ-CO^®Disp, which indicated for the prevention of malaria in children was pre-qualified by World Health Organization (WHO), and around 175 million children in high malaria transmission African countries have benefited from the “Seasonal Malaria Chemoprevention (SMC) Program”, for which SPAQ-CO^®Disp is used as the core drug. SMC with SPAQ-CO^®Disp effectively reduced the morbidity of malaria in children under five years old in Africa.  

ESG Performance has been Affirmed by Many International Rating Agencies

With the rise of ESG-themed investment in recent years, global investors are paying increasing attention to the ESG performance of enterprises. Fosun International’s ESG performance has been affirmed by many international rating agencies. Its latest MSCI ESG rating jumped from A to AA and it is currently the only conglomerate in Greater China with an MSCI ESG rating of AA. It was also selected as a constituent of the MSCI CHINA ESG LEADERS 10-40 Index, and its Hang Seng Sustainability Rating was A, and was selected as a constituent of the Hang Seng Corporate Sustainability Benchmark Index (HSSUSB) and the Hang Seng ESG 50 Index. Fosun International's FTSE Russell ESG Rating and S&P CSA ESG Scores have also improved significantly, with both ratings higher than the industry average.

The judging committee of the association pointed out that various rating agencies have assigned excellent ratings and scores to Fosun International, which demonstrates the market's recognition of Fosun International's outstanding performance in sustainable development, including ESG.

About Fosun

Founded in 1992, Fosun is a global innovation-driven consumer group dedicated to providing high-quality products and services for families around the world in Health, Happiness, Wealth, and Intelligent Manufacturing segments. In 2007, Fosun International Limited was listed on the main board of the Hong Kong Stock Exchange (stock code: 00656.HK). In 2021, Fosun International’s total revenue was RMB161.3 billion and total assets amounted to RMB806.4 billion. Fosun International ranks No.589 on the 2022 Forbes Global 2000 List, with a MSCI ESG rating of AA.